Client News
Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Motif Bio plc: Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes
InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
Heidelberg Pharma Receives Milestone Payment from Partner Telix
Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
Ergomed Strengthens Executive Team with Appointment of Richard Barfield, Formerly of Chiltern International, as Chief Financial Officer
Abivax Receives First Clinical Trial Authorization for ABX464 Phase 2a Study in Patients with Rheumatoid Arthritis
AYOXXA launches next generation LUNARISTM Reader to facilitate translational research in academic and industrial laboratories
Rentschler Fill Solutions appoints Dr. Friedrich Sernetz as Chief Executive Officer